Neuraxpharm Group, a European specialty pharmaceutical company focused on the central nervous system, has expanded its operations in Southern Europe with the launch of Neuraxpharm Portugal, it was reported yesterday.
The new office will be part of the company's Southern European Region that includes Italy, Spain and now Portugal.
Javier Mercade, general manager for Italy and Spain, was named as head of the Southern Region earlier this year, which will include Spain, Italy and Portugal. The company has also named Teng Dias as commercial director of the Portugal business.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer